Park Ha Biological Technology Co Ltd (NASDAQ: PHH) has a higher price-to-earnings ratio of 413.64x compared to its average ratio, Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for PHH is 4.82M, and currently, shorts hold a 1.37% of that float. The average trading volume for PHH on June 20, 2025 was 391.56K shares.
PHH) stock’s latest price update
Park Ha Biological Technology Co Ltd (NASDAQ: PHH)’s stock price has surge by 9.31relation to previous closing price of 21.91. Nevertheless, the company has seen a 16.94% surge in its stock price over the last five trading sessions. businesswire.com reported 2025-06-16 that SAN FRANCISCO–(BUSINESS WIRE)–PHH Mortgage, one of the largest mortgage servicers in the U.S., and a subsidiary of Onity Group Inc. (NYSE: ONIT), is expanding its partnership with Blend Labs, Inc. (NYSE: BLND) to deliver faster, more seamless refinance and home equity experiences for borrowers. PHH Mortgage has expanded its use of Blend’s technology platform, already powering its mortgage lending operations, to now include Rapid Refi and Rapid Home Equity. As part of its ongoing digital trans.
PHH’s Market Performance
Park Ha Biological Technology Co Ltd (PHH) has seen a 16.94% rise in stock performance for the week, with a 68.90% gain in the past month and a 146.40% surge in the past quarter. The volatility ratio for the week is 2.05%, and the volatility levels for the past 30 days are at 5.42% for PHH. The simple moving average for the past 20 days is 40.58% for PHH’s stock, with a 127.53% simple moving average for the past 200 days.
PHH Trading at 58.83% from the 50-Day Moving Average
After a stumble in the market that brought PHH to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 5.88% of gains for the given period.
Stock Fundamentals for PHH
Current profitability levels for the company are sitting at:
- 0.33 for the present operating margin
- 0.92 for the gross margin
The net margin for Park Ha Biological Technology Co Ltd stands at 0.2. The total capital return value is set at 0.51. Equity return is now at value 38.00, with 17.89 for asset returns.
Based on Park Ha Biological Technology Co Ltd (PHH), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 13.66.
Currently, EBITDA for the company is 0.82 million with net debt to EBITDA at -0.58. When we switch over and look at the enterprise to sales, we see a ratio of 265.0. The receivables turnover for the company is 2.15for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.15.
Conclusion
In conclusion, Park Ha Biological Technology Co Ltd (PHH) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
